Pittsburgh Attorneys for Janumet/Januvia Complications
Januvia and Janumet are similar drugs manufactured by Merck & Co. to treat Type 2 diabetes. These drugs have two major ingredients, sitagliptin and metformin (also manufactured by Merck), intended to control blood sugar.
While these drugs were approved by the Food and Drug Administration, they have been linked to pancreatic cancer and pancreatitis. Patients who have been diagnosed with these conditions after using Januvia and Janumet have filed suits against Merck, claiming that they were never informed of the risk.
Helping You Understand Your Options with Januvia or Janumet Lawsuits
If you have been diagnosed with a serious health condition, such as pancreatitis or pancreatic cancer, after using Januvia or Janumet, contact us. At Robert Peirce & Associates, P.C., our litigation attorneys are committed to aggressively fighting to hold drug manufacturers accountable for the pain and suffering you have experienced because they neglected to inform you of the serious potential side effects.
Call our Pittsburgh law offices today at (844) 383-0565 to schedule a consultation and discuss your legal options for seeking damages.
After nearly 100 instances of pancreatitis in Januvia patients were reported to the FDA between 2006 and 2009, the FDA issued safety warnings about the active ingredients in the drugs.
Often, damage is done, but symptoms may take time to show themselves. If you used these drugs in the past and were diagnosed with pancreatic cancer or pancreatitis, you likely have a claim.
Our Pittsburgh defective drug lawyers will sit down and listen to your story, providing you with a clear understanding of your legal options and how we can help you hold the manufacturers accountable for the pain you have experienced.